203 results
Page 5 of 11
6-K
EX-99.5
nj9m9pxjgy i8b0kp
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.2
6v4cf048sowf999f3l9x
8 Sep 20
Form 6K for May 2020
1:15pm
6-K
EX-99.1
iwcfk0f1xs0e0dq8rbr
8 Sep 20
Form 6K for May 2020
1:15pm
6-K
EX-99.1
j105vop 01iodr70kt3
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.1
rqoypceqcm9fdi cxv
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.1
8tyvzc
22 Apr 20
Replicel Postpones Filing of Annual Financial Statements and MD&A Due to COVID-19 Related Delays
1:56pm
6-K
EX-99.1
oazpwh7c6xy
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm
6-K
EX-99.1
81opptrbtuw
26 Nov 19
RepliCel Provides 2019 Year-End Update
12:41pm
6-K
EX-99.1
eerxic5umqyocg7 82hk
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.5
fooai
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
vx74rnvpjzyfd
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
a782c90
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.2
9ea apr9y
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.3
dxqaozi2ezsd11r08kpy
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
cmel6u5 54wuo
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
3mdo2rn i7hw8p5z
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.1
cxbtwxwbgwup4x
26 Mar 19
Current report (foreign)
1:45pm
6-K
EX-99.1
wikl26gea5evx ijt
6 Mar 19
51-102F3 Material Change Report
4:53pm